Methylenedioxybenzylamphetamine

Methylenedioxybenzylamphetamine

Names
IUPAC name 1-(1,3-benzodioxol-5-yl)-N-benzylpropan-2-amine
Identifiers
CAS Number	65033-29-6 Y
Jmol 3D model	Interactive image
UNII	QR8242661A N
SMILES C1=C3C(=CC=C1CC(C)NCC2=CC=CC=C2)OCO3
Properties
Chemical formula	C17H19NO2
Molar mass	269.343 g/mol
Vapor pressure	{{{value}}}
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

MDBZ, or 3,4-methylenedioxy-N-benzylamphetamine, is a lesser-known psychedelic drug. It is the N-benzyl derivative of MDA. MDBZ was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 150 mg, and the duration unknown. MDBZ produces few to no effects. Very few data exist about the pharmacological properties, metabolism, and toxicity of MDBZ.

In an episode of the British spoof documentary TV show Brass Eye, David Amess MP was fooled into recording a warning against a fictitious new drug called "cake". When asked a parliamentary question about it, the Home Office incorrectly assumed Amess was referring to 3,4-methylenedioxy-N-benzylamphetamine.

See also

• Phenethylamine
• Psychedelics, dissociatives and deliriants
• MDA

External links

• MDBZ entry in PiHKAL
• MDBZ entry in PiHKAL • info